壮族与汉族育龄期多囊卵巢综合征临床表型 对比研究
Clinical Phenotype of Polycystic Ovary Syndrome in the Childbearing Age of Zhuang and Han Nationality Comparative Study
DOI: 10.12677/acm.2026.163801, PDF,    科研立项经费支持
作者: 卢羽茜, 黄秋艳*, 陈梦婷, 韦 懿, 罗小琼:右江民族医学院附属医院生殖医学中心,广西 百色
关键词: 多囊卵巢综合征壮族汉族临床表型Polycystic Ovary Syndrome Zhuang Nationality Han Nationality Clinical Phenotypes
摘要: 目的:多囊卵巢综合征(polycystic ovary syndrome, PCOS)临床表型异质性较大,可因种族和地域环境不同,壮族PCOS的研究较少,通过对比壮族汉族PCOS临床表型为个体化治疗提供参考依据。方法:2019年1月至2022年6月在右江民族医学院附属医院就诊壮族PCOS 231例和汉族PCOS 69例,记录两组的一般资料和临床特征,比较分析壮族汉族PCOS临床表型、内分泌特点等数据。结果:壮族和汉族PCOS临床表型均以A和D型为主,高雄激素占比分别75.8% & 75.4%,胰岛素抵抗占比为55.4% & 59.8%,两组在PCOS临床表型、高雄激素、AMH和HOMA-2R等对比无统计学意义。结论:壮族女性PCOS的临床表型与汉族女性PCOS类似,均以高雄激素和胰岛素抵抗为主要表现。
Abstract: Objective: Polycystic ovary syndrome (PCOS) exhibits significant clinical heterogeneity, which may vary due to differences in race and regional environments. There is limited research on PCOS in the Zhuang population. A comparison of the clinical phenotypes of PCOS between Zhuang and Han populations can provide a reference for individualized treatment. Methods: 231 Zhuang women and 69 Han women diagnosed with PCOS in the affiliated hospital of Youjiang Medical University for Nationalities from January 2019 to June 2022 were included, the clinical classification and characteristics of PCOS were compared. The general information and clinical characteristics of the two groups were recorded, and the clinical phenotype, endocrine characteristics and other data of Zhuang and Han PCOS were compared and analysed. Results: The phenotypes of PCOS in Zhuang and Han women are mainly A and D, with the proportion of PCOS hyper androgen is 75.8% & 75.4% and the proportion of insulin resistance is 55.4% & 59.8%. There was no statistical difference between the two groups in clinical classification, hyper androgen and hirsutism, AMH and HOMA-2R. Conclusion: The clinical classification of PCOS in Zhuang women is similar to that in Han women, with the main manifestations of hyperandrogenism and insulin resistance.
文章引用:卢羽茜, 黄秋艳, 陈梦婷, 韦懿, 罗小琼. 壮族与汉族育龄期多囊卵巢综合征临床表型 对比研究[J]. 临床医学进展, 2026, 16(3): 370-377. https://doi.org/10.12677/acm.2026.163801

参考文献

[1] Legro, R.S., Arslanian, S.A., Ehrmann, D.A., Hoeger, K.M., Murad, M.H., Pasquali, R., et al. (2013) Diagnosis and Treatment of Polycystic Ovary Syndrome: An Endocrine Society Clinical Practice Guideline. The Journal of Clinical Endocrinology & Metabolism, 98, 4565-4592. [Google Scholar] [CrossRef] [PubMed]
[2] Walter, K. (2022) What Is Polycystic Ovary Syndrome? JAMA, 327, 294. [Google Scholar] [CrossRef] [PubMed]
[3] Li, R., Zhang, Q., Yang, D., Li, S., Lu, S., Wu, X., et al. (2013) Prevalence of Polycystic Ovary Syndrome in Women in China: A Large Community-Based Study. Human Reproduction, 28, 2562-2569. [Google Scholar] [CrossRef] [PubMed]
[4] Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group (2004) Revised 2003 Consensus on Diagnostic Criteria and Long-Term Health Risks Related to Polycystic Ovary Syndrome (PCOs). Human Reproduction, 19, 41-47. [Google Scholar] [CrossRef] [PubMed]
[5] Salameh, W.A., Redor-Goldman, M.M., Clarke, N.J., Mathur, R., Azziz, R. and Reitz, R.E. (2014) Specificity and Predictive Value of Circulating Testosterone Assessed by Tandem Mass Spectrometry for the Diagnosis of Polycystic Ovary Syndrome by the National Institutes of Health 1990 Criteria. Fertility and Sterility, 101, 1135-1141.e2. [Google Scholar] [CrossRef] [PubMed]
[6] Guo, L., Gordon, N.P., Chandra, M., Dayo, O. and Lo, J.C. (2021) The Risks of Polycystic Ovary Syndrome and Diabetes Vary by Ethnic Subgroup among Young Asian Women. Diabetes Care, 44, e129-e130. [Google Scholar] [CrossRef] [PubMed]
[7] 中国医师协会内分泌代谢科医师分会. 多囊卵巢综合征诊治内分泌专家共识[J]. 中华内分泌代谢杂志, 2018, 34(1): 1-7.
[8] Cuney, T.K., Kabi, K.S., Iiay, G., et al. (2013) Extended High Frequency Audiometry in Polycystic Ovary Syndrome. The Scientific World Journal, 2013, Article ID: 482689.
[9] 中华医学会妇产科学分会内分泌学组及指南专家组. 多囊卵巢综合征中国诊疗指南[J]. 中华妇产科杂志, 2018, 53(1): 2-6.
[10] 中华医学会糖尿病学分会胰岛素抵抗学组(筹). 胰岛素抵抗评估方法和应用的专家指导意见[J]. 中华糖尿病杂志, 2018, 10(6): 377-385.
[11] Sun, X., Wu, X., Duan, Y., Liu, G., Yu, X. and Zhang, W. (2017) Family-based Association Study of rs17300539 and rs12495941 Polymorphism in Adiponectin Gene and Polycystic Ovary Syndrome in a Chinese Population. Medical Science Monitor, 23, 78-84. [Google Scholar] [CrossRef] [PubMed]
[12] Ntumy, M., Maya, E., Lizneva, D., Adanu, R. and Azziz, R. (2019) The Pressing Need for Standardization in Epidemiologic Studies of PCOS across the Globe. Gynecological Endocrinology, 35, 1-3. [Google Scholar] [CrossRef] [PubMed]
[13] Farhadi-Azar, M., Behboudi-Gandevani, S., Rahmati, M., Mahboobifard, F., Khalili Pouya, E., Ramezani Tehrani, F., et al. (2022) The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study. Frontiers in Endocrinology, 13, Article 825528. [Google Scholar] [CrossRef] [PubMed]
[14] Jamil, A.S., Alalaf, S.K., Al-Tawil, N.G. and Al-Shawaf, T. (2015) A Case-Control Observational Study of Insulin Resistance and Metabolic Syndrome among the Four Phenotypes of Polycystic Ovary Syndrome Based on Rotterdam Criteria. Reproductive Health, 12, Article No. 7. [Google Scholar] [CrossRef] [PubMed]
[15] Elasam, A.N., Ahmed, M.A., Ahmed, A.B.A., Sharif, M.E., Abusham, A., Hassan, B., et al. (2022) The Prevalence and Phenotypic Manifestations of Polycystic Ovary Syndrome (PCOS) among Infertile Sudanese Women: A Cross-Sectional Study. BMC Womens Health, 22, Article No. 165. [Google Scholar] [CrossRef] [PubMed]
[16] Bahadur, A., Mundhra, R., Kashibhatla, J., Rajput, R., Verma, N. and Kumawat, M. (2020) Prevalence of Metabolic Syndrome among Women with Different PCOS Phenotypes—A Prospective Study. Gynecological Endocrinology, 37, 21-25. [Google Scholar] [CrossRef] [PubMed]
[17] Ma, L., Cao, Y., Ma, Y. and Zhai, J. (2021) Association between Hyperandrogenism and Adverse Pregnancy Outcomes in Patients with Different Polycystic Ovary Syndrome Phenotypes Undergoing in Vitro Fertilization/Intracytoplasmic Sperm Injection: A Systematic Review and Meta-Analysis. Gynecological Endocrinology, 37, 694-701. [Google Scholar] [CrossRef] [PubMed]
[18] Wang, Q., Zheng, Y., Li, P., Zhang, G., Gao, S., Wang, Z., et al. (2022) Increased Risk of Abortion after Frozen-Thawed Embryo Transfer in Women with Polycystic Ovary Syndrome Phenotypes A and D. Scientific Reports, 12, Article No. 14852. [Google Scholar] [CrossRef] [PubMed]
[19] Dehghani Firoozabadi, A., Firouzabadi, R.D., Eftekhar, M., Sadat Tabatabaei Bafghi, A. and Shamsi, F. (2020) Maternal and Neonatal Outcomes among Pregnant Women with Different Polycystic Ovary Syndrome Phenotypes: A Cross-Sectional Study. International Journal of Reproductive BioMedicine (IJRM), 18, 339-346. [Google Scholar] [CrossRef] [PubMed]
[20] 梁雪飞, 万江帆. 壮族和汉族多囊卵巢综合征患者脂联素基因rs1501299位点的多态性比较[J]. 广西医学, 2019, 41(4): 413-415.
[21] 李艳, 刘洋. 多囊卵巢综合征种族差异的研究进展[J]. 中华生殖与避孕杂志, 2025, 45(5): 526-531.
[22] 李丽, 张劲松, 王艳. 胰岛素受体底物1基因多态性与多囊卵巢综合征胰岛素抵抗的关联研究[J]. 中华内分泌代谢杂志, 2018, 34(5): 385-390.
[23] 黄秋艳, 梁桂宁, 李牡艳. 壮族多囊卵巢综合征患者PPARγ基因多态性与胰岛素抵抗的相关性分析[J]. 广西医学, 2020, 42(12): 1521-1525.
[24] 韦叶生, 黄瑞雅, 农天雷. 壮族人群KCNJ11基因多态性与代谢综合征的关联研究[J]. 右江医学, 2019, 47(8): 565-569.
[25] 陆光润, 覃明, 韦玉芳. 广西壮族传统饮食结构与代谢相关疾病的流行病学调查[J]. 中国食物与营养, 2021, 27(3): 75-79.
[26] 中华医学会内分泌学分会. 胰岛素抵抗相关代谢疾病诊疗指南(2022版) [J]. 中华内分泌代谢杂志, 2022, 38(1): 1-20.
[27] 陈莉, 刘军, 黄华. 广西壮族聚居区土壤重金属污染现状及人体暴露风险评估[J]. 环境科学学报, 2020, 40(7): 2568-2576.
[28] 王强, 赵静, 孙晓红. 环境内分泌干扰物对胰岛素抵抗的影响及机制研究进展[J]. 环境与健康杂志, 2021, 38(4): 365-370.
[29] 周雪, 吴德生, 李敏. 镉暴露对小鼠胰岛素敏感性及肝脏胰岛素信号通路的影响[J]. 毒理学杂志, 2019, 33(2): 108-112.
[30] 梁晓萍, 韦彩玲, 黄玉珍. 壮族农村女性体力活动水平与多囊卵巢综合征代谢指标的相关性研究[J]. 实用预防医学, 2022, 29(6): 698-701.
[31] 王卫庆, 万沁, 马建华, 等. 中国成人体重管理指南[J]. 中华内分泌代谢杂志, 2025, 41(11): 891-907.